Annovis Bio Q1 2026 Earnings EPS Misses Estimates as PreClinical Spending Intensifies NetSol Technologies NTWK Q1 2026 Earnings Positive EPS Results Amid Limited Disclosure Falcons Beyond Global FBYD Q1 2026 Earnings Negative EPS Weighs on Shares ESLA Q1 2026 Earnings EPS Misses Estimates by Wide Margin as ClinicalStage Biotech Continues RD Spending iQIYI Q1 2026 Earnings EPS Misses Estimates as Profitability Challenges Persist PHIO Q1 2026 Earnings EPS Misses Estimates Amid Continued Clinical Trials Focus